业务
货币单位:EUR
2025/FY
名称营收比例
Research and development of PRAME-directed immunotherapies that harness the power of T cells for4,826.6万100.00%
地区
货币单位:EUR
2025/FY
名称营收比例
Moderna, United States3,724.7万77.17%
Bristol-Myers-Squibb (BMS) United States1,101.9万22.83%